Scott Schlackman is Director at MEDIFAST INC (MED). They have made 12 open-market trades across 1 company since 2019, most recently 2026-05-26.
CIK 0001645617
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
6 open-market purchases totalling $74K since 2022, against 6 sales. Across 6 scored buys the stock is down 11.6% at ninety days, and 16.7 points behind the S&P over the same stretch.
6 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| MED | 42,228 | $502K |
Shares reported on the most recent Form 4, priced at the 2026-05-28 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 50% | 33% | 17% |
| Avg Move | -1.9% | -2.5% | -11.6% |
| Alpha | -2.4% | -3.8% | -16.7% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MED | BUY | 2026-05-08 | 2026-05-12 | $12.59 | $63K | +0.1% | -5.5% | -4.0% |
| MED | SELL | 2024-03-08 | 2024-03-12 | $39.44 | $320K | -3.6% | -11.3% | -41.5% |
| MED | BUY | 2023-11-07 | 2023-11-09 | $69.75 | $4K | +1.0% | +14.6% | -17.0% |
| MED | BUY | 2023-08-08 | 2023-08-10 | $91.30 | $4K | -8.1% | -10.3% | -28.6% |
| MED | BUY | 2023-05-09 | 2023-05-11 | $88.51 | $1K | -1.1% | -9.9% | +4.7% |
| MED | SELL | 2023-03-10 | 2023-03-14 | $108.68 | $478K | -7.0% | -6.1% | -23.8% |
| MED | BUY | 2023-02-07 | 2023-02-09 | $125.19 | $1K | -5.9% | -4.1% | -20.4% |
| MED | BUY | 2022-11-08 | 2022-11-10 | $110.99 | $1K | +2.7% | +0.1% | -4.0% |
| MED | SELL | 2021-05-19 | 2021-05-21 | $310.16 | $591K | -0.1% | -16.2% | -31.2% |
| MED | SELL | 2020-06-04 | 2020-06-08 | $107.48 | $509K | +2.7% | +29.0% | +41.2% |
| MED | SELL | 2019-03-08 | 2019-03-12 | $130.92 | $524K | -7.7% | +1.2% | +1.9% |
| MED | SELL | 2019-03-05 | 2019-03-07 | $129.80 | $325K | +5.3% | +7.4% | +2.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.